Encompass Health Corporation $EHC Shares Sold by Jensen Investment Management Inc.

Jensen Investment Management Inc. lowered its position in shares of Encompass Health Corporation (NYSE:EHC) by 12.0% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 50,660 shares of the company’s stock after selling 6,900 shares during the quarter. Jensen Investment Management Inc. owned about 0.05% of Encompass Health worth $6,435,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the company. Navellier & Associates Inc. acquired a new position in Encompass Health in the third quarter valued at approximately $203,000. Johnson Investment Counsel Inc. purchased a new stake in shares of Encompass Health during the third quarter worth approximately $284,000. Linden Thomas Advisory Services LLC raised its position in shares of Encompass Health by 2.8% in the third quarter. Linden Thomas Advisory Services LLC now owns 15,461 shares of the company’s stock valued at $1,964,000 after buying an additional 416 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in Encompass Health by 16.1% in the 3rd quarter. Smartleaf Asset Management LLC now owns 1,607 shares of the company’s stock valued at $202,000 after acquiring an additional 223 shares during the last quarter. Finally, Savant Capital LLC increased its holdings in shares of Encompass Health by 14.2% in the third quarter. Savant Capital LLC now owns 3,565 shares of the company’s stock valued at $453,000 after purchasing an additional 444 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Price Performance

EHC stock opened at $108.90 on Wednesday. The company has a market capitalization of $10.96 billion, a PE ratio of 19.66, a P/E/G ratio of 2.05 and a beta of 0.73. The business’s fifty day moving average price is $103.99 and its 200 day moving average price is $114.50. Encompass Health Corporation has a 12-month low of $92.53 and a 12-month high of $127.99. The company has a current ratio of 1.08, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The business had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same quarter last year, the company earned $1.17 EPS. The business’s quarterly revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current year.

Wall Street Analyst Weigh In

EHC has been the topic of a number of analyst reports. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Barclays upped their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $143.29.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.